The evaluation of clinical outcomes assessments and digital health technologies in clinical trials for obesity.

ABSTRACT:

Background

Clinical trials for obesity have traditionally focused on weight loss and resolution of comorbidities as primary outcomes. However, secondary outcomes, such as the impact of weight reduction on patient experience, like health-related quality of life (HRQoL), have increasingly been recognized as important. Therefore, a review was conducted to determine the Clinical Outcome Assessments (COAs) and Digital Health Technologies (DHTs) used in clinical trials for obesity to assess the patient experience.

Methods

Two clinical trial databases (United States & European Union) were reviewed to identify Phase 2-4 clinical trials for obesity (2018-2023). A targeted literature review was also conducted using the OVID database to identify clinical trial for obesity publications

SUBMITTER: Goetz IA 

PROVIDER: S-EPMC11842654 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature